Urinary FLCs were measured by turbidimetry on a Roche Modular P analyser using the Freelite™ immunoassay (The Binding Site Group Ltd, Birmingham, UK). To correct for variations in urine concentration, urinary FLCs were divided by urine creatinine concentration to give urinary FLC/creatinine (FLC/Cr) ratios in mg/mmol, i.e. a kappa/creatinine ratio (KCR) and a lambda/creatinine ratio (LCR). Serum creatinine measurements were performed on a Roche Modular analyser using a rate-blanked and compensated Jaffe reaction, and eGFR was calculated using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation [20 (link)]. Serum kappa (κ) and lambda (λ) FLC concentrations were measured by nephelometry on a Dade-Behring BN™ II System (Siemens AG, Erlangen, Germany) using the Freelite™ assay. Urine ACR was measured using a Roche Hitachi 702 analyser. Other biochemistry testing was performed by the local clinical laboratories in accordance with the current standard of care.
Modular analyser
The Modular Analyser is a versatile and automated laboratory instrument designed for clinical diagnostics. It is capable of performing a wide range of analytical tests efficiently and accurately. The core function of the Modular Analyser is to automate and streamline various clinical laboratory processes, enabling healthcare professionals to obtain reliable test results in a timely manner.
Lab products found in correlation
15 protocols using modular analyser
Measuring Urinary and Serum Free Light Chains
Urinary FLCs were measured by turbidimetry on a Roche Modular P analyser using the Freelite™ immunoassay (The Binding Site Group Ltd, Birmingham, UK). To correct for variations in urine concentration, urinary FLCs were divided by urine creatinine concentration to give urinary FLC/creatinine (FLC/Cr) ratios in mg/mmol, i.e. a kappa/creatinine ratio (KCR) and a lambda/creatinine ratio (LCR). Serum creatinine measurements were performed on a Roche Modular analyser using a rate-blanked and compensated Jaffe reaction, and eGFR was calculated using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation [20 (link)]. Serum kappa (κ) and lambda (λ) FLC concentrations were measured by nephelometry on a Dade-Behring BN™ II System (Siemens AG, Erlangen, Germany) using the Freelite™ assay. Urine ACR was measured using a Roche Hitachi 702 analyser. Other biochemistry testing was performed by the local clinical laboratories in accordance with the current standard of care.
Stress, Inflammation, and Physical Measures
Creatinine Measurement Protocol Conversion
Measuring High-Sensitivity C-Reactive Protein
Lipidomics Quantification Validation
Total triacylglycerol and cholesterol concentrations, as specified by lipidomics, were correlated with quantities obtained by standard enzymatic methods on a MODULAR analyser (Roche, Indianapolis, IN). The specified concentrations correlated well for total triacylglycerol (relative error = -5.48 ± 8.77%, adj. R2 = 0.9754, slope = 1.0151) and total cholesterol (relative error = 7.61 ± 5.44%, adj. R2 = 0.9362, slope = 0.9833). The data comparison uncovered 1 experimental outlayer in 91 analyzed plasma samples. For this sample total triglyceride differed by 7.9x; total cholesterol by 1.6x.
Creatinine, eGFR, and CRP Measurements
Bone Turnover Markers Assessment
Calculating eGFR and Assessing Albuminuria
Serum and Bile Acid Biochemical Analysis
Renal Function and Complement Levels in Lupus Nephritis
In the LN group, a subset of patients was sampled before establishing this method. Such samples were analysed by nephelometry array (Beckman Coulter). The normal level using this method was 0.5–1.2 g/L for C3 and of 0.1–0.4 g/L for C4.
Anti-dsDNA antibodies were routinely analysed over the years using different methods at the Department of Clinical Immunology at the Karolinska University Hospital.
For statistical purposes, and considering the changes in laboratory methods, C3, C4 and anti-dsDNA were considered as categorical variables in this study, based on their being outside or within reference ranges.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!